Rare diseases
Investigational molecules
Locations
Back to Belgium201 clinical trials in Charleroi, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Omalizumab and Mepolizumab for Patients with Severe Allergic and Eosinophilic Asthma
BelgiumStudy Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy
BelgiumStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
BelgiumStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
BelgiumStudy Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer
BelgiumStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
BelgiumStudy on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis
BelgiumStudy of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
BelgiumStudy on the Safety of Avelumab, Lorlatinib, and Axitinib for Cancer Patients Continuing from Previous Trials
BelgiumStudy of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
BelgiumTitle: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment
BelgiumStudy of regorafenib and nivolumab with radiotherapy for patients with stage II-III rectal cancer before surgery
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in breast cancer, lung cancer, and head and neck cancers. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Multiple trials investigating personalized medicine approaches and biomarker-driven treatments.
Research examining treatments for coronary artery disease and post-cardiac arrest care. Trials focus on innovative stent technologies and antiplatelet therapy optimization.
Emphasis on improving patient outcomes through targeted interventional approaches.
Clinical investigations targeting inflammatory skin conditions and immune-mediated disorders. Studies evaluate novel treatments for psoriasis and other dermatological conditions.
Focus on developing targeted therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
